| Year |
Citation |
Score |
| 2022 |
Sodji QH, Nambiar DK, Viswanathan V, von Eyben R, Colburg D, Binkley MS, Li CG, Olcina MM, Chang DT, Le QT, Giaccia AJ. The Combination of Radiotherapy and Complement C3a Inhibition Potentiates Natural Killer cell Functions Against Pancreatic Cancer. Cancer Research Communications. 2: 725-738. PMID 35937458 DOI: 10.1158/2767-9764.crc-22-0069 |
0.451 |
|
| 2021 |
Bader SB, Ma TS, Simpson CJ, Liang J, Maezono SEB, Olcina MM, Buffa FM, Hammond EM. Replication catastrophe induced by cyclic hypoxia leads to increased APOBEC3B activity. Nucleic Acids Research. PMID 34197599 DOI: 10.1093/nar/gkab551 |
0.536 |
|
| 2020 |
Olcina MM, Kim RK, Balanis NG, Li CG, von Eyben R, Graeber TG, Ricklin D, Stucki M, Giaccia AJ. Intracellular C4BPA Levels Regulate NF-κB-Dependent Apoptosis. Iscience. 23: 101594. PMID 33205012 DOI: 10.1016/j.isci.2020.101594 |
0.478 |
|
| 2018 |
Olcina MM, Balanis NG, Kim RK, Aksoy BA, Kodysh J, Thompson MJ, Hammerbacher J, Graeber TG, Giaccia AJ. Mutations in an Innate Immunity Pathway Are Associated with Poor Overall Survival Outcomes and Hypoxic Signaling in Cancer. Cell Reports. 25: 3721-3732.e6. PMID 30590044 DOI: 10.1016/J.Celrep.2018.11.093 |
0.477 |
|
| 2018 |
Olcina MM, Kim RK, Melemenidis S, Graves EE, Giaccia AJ. The tumour microenvironment links complement system dysregulation and hypoxic signalling. The British Journal of Radiology. 20180069. PMID 29544344 DOI: 10.1259/Bjr.20180069 |
0.481 |
|
| 2017 |
Ng N, Purshouse K, Foskolou IP, Olcina MM, Hammond EM. Challenges to DNA replication in hypoxic conditions. The Febs Journal. PMID 29288533 DOI: 10.1111/febs.14377 |
0.536 |
|
| 2017 |
Foskolou IP, Jorgensen C, Leszczynska KB, Olcina MM, Tarhonskaya H, Haisma B, D'Angiolella V, Myers WK, Domene C, Flashman E, Hammond EM. Ribonucleotide Reductase Requires Subunit Switching in Hypoxia to Maintain DNA Replication. Molecular Cell. PMID 28416140 DOI: 10.1016/j.molcel.2017.03.005 |
0.666 |
|
| 2016 |
Kariolis MS, Miao YR, Diep A, Nash SE, Olcina MM, Jiang D, Jones DS, Kapur S, Mathews II, Koong AC, Rankin EB, Cochran JR, Giaccia AJ. Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies. The Journal of Clinical Investigation. PMID 27893463 DOI: 10.1172/Jci85610 |
0.5 |
|
| 2016 |
Johnson RW, Finger EC, Olcina MM, Vilalta M, Aguilera T, Miao Y, Merkel AR, Johnson JR, Sterling JA, Wu JY, Giaccia AJ. Erratum: Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow. Nature Cell Biology. 18: 1260. PMID 27784904 DOI: 10.1038/ncb3433 |
0.399 |
|
| 2016 |
Johnson RW, Finger EC, Olcina MM, Vilalta M, Aguilera T, Miao Y, Merkel AR, Johnson JR, Sterling JA, Wu JY, Giaccia AJ. Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow. Nature Cell Biology. PMID 27642788 DOI: 10.1038/Ncb3408 |
0.416 |
|
| 2016 |
Olcina MM, Giaccia AJ. Reducing radiation-induced gastrointestinal toxicity - the role of the PHD/HIF axis. The Journal of Clinical Investigation. PMID 27548524 DOI: 10.1172/Jci84432 |
0.458 |
|
| 2016 |
Olcina MM, Giaccia AJ, Hammond EM. Isolation of Proteins on Nascent DNA in Hypoxia and Reoxygenation Conditions. Advances in Experimental Medicine and Biology. 899: 27-40. PMID 27325260 DOI: 10.1007/978-3-319-26666-4_3 |
0.669 |
|
| 2016 |
Foskolou IP, Biasoli D, Olcina MM, Hammond EM. Measuring DNA Replication in Hypoxic Conditions. Advances in Experimental Medicine and Biology. 899: 11-25. PMID 27325259 DOI: 10.1007/978-3-319-26666-4_2 |
0.632 |
|
| 2016 |
Leszczynska KB, Göttgens EL, Biasoli D, Olcina MM, Ient J, Anbalagan S, Bernhardt S, Giaccia AJ, Hammond EM. Mechanisms and consequences of ATMIN repression in hypoxic conditions: roles for p53 and HIF-1. Scientific Reports. 6: 21698. PMID 26875667 DOI: 10.1038/Srep21698 |
0.67 |
|
| 2014 |
Olcina MM, Grand RJ, Hammond EM. ATM activation in hypoxia - causes and consequences. Molecular & Cellular Oncology. 1: e29903. PMID 27308313 DOI: 10.4161/mco.29903 |
0.695 |
|
| 2014 |
Olcina MM, Hammond EM. WIP1 and senescence: oxygen matters. Cell Cycle (Georgetown, Tex.). 13: 1062. PMID 24584094 DOI: 10.4161/cc.28385 |
0.536 |
|
| 2013 |
Olcina MM, Foskolou IP, Anbalagan S, Senra JM, Pires IM, Jiang Y, Ryan AJ, Hammond EM. Replication stress and chromatin context link ATM activation to a role in DNA replication Molecular Cell. 52: 758-766. PMID 24268576 DOI: 10.1016/j.molcel.2013.10.019 |
0.708 |
|
| 2013 |
Cazares-Körner C, Pires IM, Swallow ID, Grayer SC, O'Connor LJ, Olcina MM, Christlieb M, Conway SJ, Hammond EM. CH-01 is a hypoxia-activated prodrug that sensitizes cells to hypoxia/reoxygenation through inhibition of Chk1 and Aurora A. Acs Chemical Biology. 8: 1451-9. PMID 23597309 DOI: 10.1021/cb4001537 |
0.684 |
|
| 2013 |
Hewings DS, Fedorov O, Filippakopoulos P, Martin S, Picaud S, Tumber A, Wells C, Olcina MM, Freeman K, Gill A, Ritchie AJ, Sheppard DW, Russell AJ, Hammond EM, Knapp S, et al. Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands. Journal of Medicinal Chemistry. 56: 3217-27. PMID 23517011 DOI: 10.1021/Jm301588R |
0.546 |
|
| 2010 |
Olcina M, Lecane PS, Hammond EM. Targeting hypoxic cells through the DNA damage response. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5624-9. PMID 20876254 DOI: 10.1158/1078-0432.CCR-10-0286 |
0.536 |
|
| Show low-probability matches. |